Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-10

Clinical Trial Update: Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy

View source ↗

Summary

A Masaryk University-sponsored trial is evaluating ultrasound-detected hematoma risk after needle EMG in patients taking direct-acting anticoagulants; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Direct-acting oral anticoagulants (DOACs) (direct-acting oral anticoagulants)

Snippet

Sponsor: Masaryk University | Conditions: Direct Acting Anticoagulant Adverse Reaction, Needle Injury | Status: RECRUITING